UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 497

Sortiert nach

Repurposing metformin for the prevention of cancer and cancer recurrence

Diabetologia, 2017-09, Vol.60 (9), p.1639-1647

2017

Volltextzugriff (PDF)

Long-Term Survival of Participants in the Prostate Cancer Prevention Trial

The New England journal of medicine, 2013-08, Vol.369 (7), p.603-610

2013

Volltextzugriff (PDF)

Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

JAMA : the journal of the American Medical Association, 2011-10, Vol.306 (14), p.1549

2011

Volltextzugriff (PDF)

Accrual Quality Improvement Program for clinical trials

Clinical trials (London, England), 2024-04, p.17407745241243027-17407745241243027

2024

Volltextzugriff (PDF)

Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer

Cancer prevention research (Philadelphia, Pa.), 2010-06, Vol.3 (6), p.696-706

2010

Volltextzugriff (PDF)

Tamoxifen for the Prevention of Breast Cancer: Current Status of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

JNCI : Journal of the National Cancer Institute, 2005-11, Vol.97 (22), p.1652-1662

2005

Volltextzugriff (PDF)

Use of Pharmacologic Interventions for Breast Cancer Risk Reduction: American Society of Clinical Oncology Clinical Practice Guideline

Journal of clinical oncology, 2013-08, Vol.31 (23), p.2942-2962

2013

Volltextzugriff (PDF)

Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data

The Lancet (British edition), 2013-05, Vol.381 (9880), p.1827-1834

2013

Volltextzugriff (PDF)

Long-Term Effects of Finasteride on Prostate Cancer Mortality

The New England journal of medicine, 2019-01, Vol.380 (4), p.393-394

2019

Volltextzugriff (PDF)

A Systematic Review and Pooled Analysis of Hypothesized versus Observed Effect Sizes in Early Phase Cancer Prevention Clinical Trials

Cancer prevention research (Philadelphia, Pa.), 2023-08, Vol.16 (8), p.471-478

2023

Volltextzugriff (PDF)

Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

JAMA : the journal of the American Medical Association, 2009-01, Vol.301 (1), p.39

2009

Volltextzugriff (PDF)

The Influence of Finasteride on the Development of Prostate Cancer

The New England journal of medicine, 2003-07, Vol.349 (3), p.215-224

2003

Volltextzugriff (PDF)

Estrogen Receptor (ESR1) mRNA Expression and Benefit From Tamoxifen in the Treatment and Prevention of Estrogen Receptor–Positive Breast Cancer

Journal of clinical oncology, 2011-11, Vol.29 (31), p.4160-4167

2011

Volltextzugriff (PDF)

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial

JAMA : the journal of the American Medical Association, 2006-06, Vol.295 (23), p.2727

2006

Volltextzugriff (PDF)

Paradoxical clinical effect of estrogen on breast cancer risk: a "new" biology of estrogen-induced apoptosis

Cancer prevention research (Philadelphia, Pa.), 2011-05, Vol.4 (5), p.633-637

2011

Volltextzugriff (PDF)

Report from an NCI Roundtable: Cancer Prevention in Primary Care

Cancer prevention research (Philadelphia, Pa.), 2022-05, Vol.15 (5), p.273-278

2022

Volltextzugriff (PDF)

Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter

The New England journal of medicine, 2004-05, Vol.350 (22), p.2239-2246

2004

Volltextzugriff (PDF)

Cancer Prevention in Primary Care: Perception of Importance, Recognition of Risk Factors and Prescribing Behaviors

The American journal of medicine, 2020-06, Vol.133 (6), p.723-732

2020

Volltextzugriff (PDF)

Establishing a Primary Care Alliance for Conducting Cancer Prevention Clinical Research at Community Sites

Cancer prevention research (Philadelphia, Pa.), 2021-11, Vol.14 (11), p.977-982

2021

Volltextzugriff (PDF)

Water insecurity, water borrowing and psychosocial stress among Daasanach pastoralists in northern Kenya

Water international, 2023, Vol.48 (1), p.63-86

2023

Volltextzugriff (PDF)

Gynecologic conditions in participants in the NSABP breast cancer prevention study of tamoxifen and raloxifene (STAR)

American journal of obstetrics and gynecology, 2011-12, Vol.205 (6), p.535.e1-535.e5

2011

Volltextzugriff (PDF)

Lessons Learned from the Impact of COVID-19 on NCI-sponsored Cancer Prevention Clinical Trials: Moving Toward Participant-centric Study Designs

Cancer prevention research (Philadelphia, Pa.), 2022-05, Vol.15 (5), p.279-284

2022

Volltextzugriff (PDF)

A Polygenic Risk Score Predicts Incident Prostate Cancer Risk in Older Men but Does Not Select for Clinically Significant Disease

Cancers, 2021-11, Vol.13 (22), p.5815

2021

Volltextzugriff (PDF)

A Phase IIa Trial of Metformin for Colorectal Cancer Risk Reduction among Individuals with History of Colorectal Adenomas and Elevated Body Mass Index

Cancer prevention research (Philadelphia, Pa.), 2020-02, Vol.13 (2), p.203-212

2020

Volltextzugriff (PDF)

1 – 25 von 497

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(380)
Mit Volltextzugriff
(379)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(496)
Japanisch
(58)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Repurposing metformin for the prevention of cancer and cancer recurrence

Long-Term Survival of Participants in the Prostate Cancer Prevention Trial

Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

Accrual Quality Improvement Program for clinical trials

Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer

Tamoxifen for the Prevention of Breast Cancer: Current Status of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

Use of Pharmacologic Interventions for Breast Cancer Risk Reduction: American Society of Clinical Oncology Clinical Practice Guideline

Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data

Long-Term Effects of Finasteride on Prostate Cancer Mortality

A Systematic Review and Pooled Analysis of Hypothesized versus Observed Effect Sizes in Early Phase Cancer Prevention Clinical Trials

Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

The Influence of Finasteride on the Development of Prostate Cancer

Estrogen Receptor (ESR1) mRNA Expression and Benefit From Tamoxifen in the Treatment and Prevention of Estrogen Receptor–Positive Breast Cancer

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial

Paradoxical clinical effect of estrogen on breast cancer risk: a "new" biology of estrogen-induced apoptosis

Report from an NCI Roundtable: Cancer Prevention in Primary Care

Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter

Cancer Prevention in Primary Care: Perception of Importance, Recognition of Risk Factors and Prescribing Behaviors

Establishing a Primary Care Alliance for Conducting Cancer Prevention Clinical Research at Community Sites

Prevention and early detection of prostate cancer

Water insecurity, water borrowing and psychosocial stress among Daasanach pastoralists in northern Kenya

Gynecologic conditions in participants in the NSABP breast cancer prevention study of tamoxifen and raloxifene (STAR)

Lessons Learned from the Impact of COVID-19 on NCI-sponsored Cancer Prevention Clinical Trials: Moving Toward Participant-centric Study Designs

A Polygenic Risk Score Predicts Incident Prostate Cancer Risk in Older Men but Does Not Select for Clinically Significant Disease

A Phase IIa Trial of Metformin for Colorectal Cancer Risk Reduction among Individuals with History of Colorectal Adenomas and Elevated Body Mass Index

Suchergebnisse filtern